re.Mind Capital
Overview
re.Mind Capital is a venture capital fund dedicated to mental and neurological health. They focus on new pharma, new modalities, brain computer interfaces and digital health . The firm seeks to invest in companies providing innovative solutions to global mental health crises and prefers to invest in companies in the neuroscience and life sciences sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neumora | Oct 2021 | Series A | - |
| Synchron | Jun 2021 | Series B | Co-investor |
| Precision Neuroscience | Jan 2023 | Series B | - |
| Delix Therapeutics | Sep 2021 | Series A | Co-investor |
| Sensorium Therapeutics | Nov 2022 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Max de Vere
Co-founder Partner
Jan Hardorp
Venture Partner
Joao Barbosa da Silva
Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is re.Mind Capital based?
re.Mind Capital is headquartered in Sliema, Sliema, Malta.
When was re.Mind Capital founded?
re.Mind Capital was founded in 2020.
How many portfolio companies does re.Mind Capital have?
re.Mind Capital has 18 portfolio companies in Caplight's dataset.
What are some companies in re.Mind Capital's portfolio?
Portfolio companies visible on Caplight include Neumora, Synchron, Precision Neuroscience, Delix Therapeutics, Sensorium Therapeutics.
What was re.Mind Capital's most recent investment shown here?
re.Mind Capital's most recent investment in this portfolio sample was in Precision Neuroscience in 2023.
What sectors does re.Mind Capital focus on?
re.Mind Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Frontier & Industrial Tech.
What company stages does re.Mind Capital focus on?
re.Mind Capital typically invests at the Early stage.
What is re.Mind Capital's AUM?
re.Mind Capital's assets under management are estimated between $100.0M and $250.0M.